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esponsibility of InstAbstract Human enterovirus 71 (EV71) is the main causative pathogen of hand, foot, and mouth
disease (HFMD) in children. The epidemic of HFMD has been a public health problem in Asia-Paciﬁc
region for decades, and no vaccine and effective antiviral medicine are available. Curcumin has been used
as a traditional medicine for centuries to treat a diversity of disorders including viral infections. In this
study, we demonstrated that curcumin showed potent antiviral effect again EV71. In Vero cells infected
with EV71, the addition of curcumin signiﬁcantly suppressed the synthesis of viral RNA, the expression
of viral protein, and the overall production of viral progeny. Similar with the previous reports, curcumin
reduced the production of ROS induced by viral infection. However, the antioxidant property of curcumin
did not contribute to its antiviral activity, since N-acetyl-L-cysteine, the potent antioxidant failed to
suppress viral replication. This study also showed that extracellular signal-regulated kinase (ERK) was6
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Curcumin inhibits the replication of enterovirus 71 285activated by either viral infection or curcumin treatment, but the activated ERK did not interfere with the
antiviral effect of curcumin, indicating ERK is not involved in the antiviral mechanism of curcumin.
Unlike the previous reports that curcumin inhibited protein degradation through ubiquitin–proteasome
system (UPS), we found that curcumin had no impact on UPS in control cells. However, curcumin did
reduce the activity of proteasomes which was increased by viral infection. In addition, the accumulation of
the short-lived proteins, p53 and p21, was increased by the treatment of curcumin in EV71-infected cells.
We further probed the antiviral mechanism of curcumin by examining the expression of GBF1 and
PI4KB, both of which are required for the formation of viral replication complex. We found that curcumin
signiﬁcantly reduced the level of both proteins. Moreover, the decreased expression of either GBF1 or
PI4KB by the application of siRNAs was sufﬁcient to suppress viral replication. We also demonstrated
that curcumin showed anti-apoptotic activity at the early stage of viral infection. The results of this study
provide solid evidence that curcumin has potent anti-EV71 activity. Whether or not the down-regulated
GBF1 and PI4KB by curcumin contribute to its antiviral effect needs further studies.
& 2014 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical
Sciences. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Enterovirus 71 (EV71) is a single stranded RNA virus which
belongs to genus Enterovirus, family Picornaviridae1. EV71
infection is often asymptomatic or causes mild manifestations
such as fever, sore throat and general malaise2. However, it may
cause severe and sometimes fatal complications such as encepha-
litis and pulmonary edema. More importantly, outbreak of EV71
infection has become a public health problem especially in the
Asia-Paciﬁc region2–4. However, since there is no speciﬁc anti-
EV71 vaccine or medicine available, treatment for the patients
with EV71 infection is simply of supportive5. Therefore, to
identify the effective anti-EV71 drugs is urgent.
Curcumin is a natural compound extracted from turmeric
(Curcuma longa). It has been used widely as a spice and coloring
agent in food6. In addition, curcumin is a constituent of many herbal
medicines used for diverse medical conditions7–9. In recent years,
extensive studies have shown that curcumin has a variety of
pharmacological properties, including anti-inﬂammation, antitumor
and antioxidant10–12. Accumulating evidence has also demonstrated
that curcumin has antiviral activity6,13–17. Viruses inhibited by the
treatment of curcumin include hepatitis C virus (HCV), hepatitis B
virus (HBV), coxsackieviurs B3 (CVB3) and human papillomavirus
(HPV)16,18–20. It has been reported that curcumin suppresses CVB3
replication via the dysregulation of the ubiquitin-proteasome system
(UPS)20. Other studies have shown that the inhibitory effect of
curcumin on HCV replication is associated with the suppression of
AKT and the inhibition on viral entry13,18, while curcumin inhibits
HBV replication via down-regulation of peroxisome proliferator-
activated receptor-gamma co-activator 1 alpha (PGC-1α), a major
metabolic co-activator of HBV16. Overall, these ﬁndings suggested
that curcumin may directly block the replication machinery of
viruses or regulate cellular metabolic or signaling pathways which
are exploited by viruses.
Although curcumin shows inhibitory effect on a variety of viruses,
whether it exerts antiviral effect on EV71 is currently unknown. In
the present study, we evaluated potential antiviral activity of curcumin
against EV71. To understand the involved mechanisms of the effect
of curcumin on viral replication, the inﬂuence of curcumin on
reactive oxygen species (ROS), apoptosis, extracellular signal-
regulated kinase (ERK) pathway and UPS were observed. Theexpression of phosphatidylinositol 4-kinase class III catalytic subunit
β (PI4KB) and Golgi brefeldin A resistant guanine nucleotide
exchange factor 1 (GBF1) were also studied.
2. Materials and methods
2.1. Chemical reagents and antibodies
Curcumin, which was dissolved in DMSO before use, and
N-acetyl-L-cysteine (NAC) were purchased from Sigma-Aldrich
(St. Louis, USA). MG132 and the Reactive Oxygen Species Assay
Kit were obtained from Beyotime (China). The ﬂuorimetric
substrate succinyl-Leu-Leu-Val-Tyr-7-amino-4-methylcoumarin
(SLLVY-AMC) was obtained from MERCK. GBF1 small inter-
fering RNA (siRNA), siRNA of PI4KB, and the scramble control
siRNA were synthesized by Takara (Dalian, China).
The monoclonal anti-enterovirus VP1 antibody was purchased
from DakoCytomation (clone5-D8/1, Denmark). Anti-PI4KB and
anti-GBF1 antibodies were from Becton Dickson. Anti-ERK1/2 and
anti-phospho-ERK1/2 antibodies were obtained from Cell Signaling
(Danvers, USA). Anti-cleaved caspase 3, antibody against the poly
(ADP-ribose) polymerase (PARP-1), and anti-p53 antibody were
purchased from Santa Cruz (Dallas, USA). Anti-β-actin and the
horseradish peroxidase-conjugated secondary antibodies were obtained
from Zhongshan Golden Bridge (Beijing, China).
2.2. Cell culture
Vero cells and RD cells (a human rhabdomyosarcoma cell line)
were maintained in the Department of Microbiology, Harbin
Medical University. Cells were cultured in complete Dulbecco's
modiﬁed Eagle medium (DMEM, Invitrogen, China) supplemen-
ted with 10% fetal bovine serum (FBS) and antibiotics (penicillin
and streptomycin) at 37 1C with 5% CO2. Vero cells were used for
the studies on EV71 infection and the effect study. RD cells were
used for siRNA transfection.
2.3. Viral infection
EV71 BrCr strain was kindly offered by Professor Mingli Wang,
Department of Microbiology, Anhui Medical University, China.
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mented with 10% FBS and antibiotics (50 U/mL penicillin and
50 mg/mL streptomycin). Cells were cultured to 80% conﬂuence,
and then infected with EV71 at a multiplicity of infection (MOI) of
10 or sham-infected with serum-free DMEM for 1 h. The media
were removed and cells were cultured in complete DMEM till
harvest. To determine the effect of curcumin on viral infection,
cells were cultured in DMEM containing curcumin at various
concentrations after EV71 infection.
2.4. Virus titration
Virus titer was assessed by 50% tissue culture infectivity dose
(TCID50) method according to the procedure described pre-
viously21,22. Brieﬂy, virus was propagated in Vero cells till 80%
CPE was reached. Cells were harvested and viruses were released
by freezing and thawing for 3 times. Cell debris was removed by
centrifugation and the supernatant was stored at 80 1C. To titer
the viruses, Vero cells were grown in 96-well plates at the density
of 1 104 cells/well. Virus was prepared in a series of 10-fold
dilution with serum-free DMEM. 100 μL of virus preparation at
each dilution was added to 3 repeated wells, respectively. After 1 h
of absorption, the culture medium was added and cells were
cultured for 24 h. Then TCID50 was calculated.
2.5. Reverse transcription-quantitative polymerase chain reaction
Viral RNA was determined by reverse transcription-quantitative
polymerase chain reaction (RT-qPCR) as described previously23. In
brief, total RNA was extracted with TRIzol (Takara, China). RT-PCR
was performed with forward primer 50-CCCCTGAATGCGGCTAAT-
30 and reverse primer 50-CAATTGTCACCATAAGCAGCCA-30. The
RNA of GAPDH was ampliﬁed as internal control with the forward
primer 50-CTCTGCTCCTCCTGTTCGAC-30 and reverse primer
50-TTAAAAGCAGCCCTGGTGAC-30. The reverse transcription
was performed at 42 1C for 30 min and followed by 40 cycles of
thermal cycling at 95 1C for 3 s and 60 1C for 30 s. The ﬂuorescence
emission of SYBR green I was monitored and analyzed by using a
LightCycler 2.0 (Roche, Basel, Switzerland).
2.6. siRNA transfection
RD cells were grown in 24-well plates to 50% conﬂuence. Cells were
transfected with siRNA of GBF1 or PI4KB (designated as si-GBF1,
and si-PI4KB, respectively) by Lipofectamine 2000 (Invitrogen). The
sequence of si-GBF1 and si-PI4KB were 30-CAACACACCUA-
CUAUCUCU-50 and 30-GGGAUGACCUUCGGCAAGAUU-50,
respectively. 48 h after transfection, cells were incubated in serum-
free DMEM without antibiotics for 1 h and then cultured in DMEM
with 10% FBS.
2.7. Western blotting
Vero cells were washed with PBS and incubated with RIPA lysis
buffer (Thermo, Rockford, USA) containing protease inhibitor PMSF
(Beyotime, Beijing, China) for 15 min on ice. Cell homogenate was
centrifuged at 12,000g for 10 min at 4 1C. Protein concentration of the
cellular homogenate was determined by Bradford assay (Bio-Rad,
Hercules, USA). Equal amount of proteins was subjected to SDS–
PAGE and then transferred to PVDF membrane. The membrane was
blocked by 5% skim milk for 4 h at 37 1C and then incubated withprimary antibody at 4 1C overnight. Membrane was washed and then
incubated with secondary antibody conjugated with horseradish
peroxidase (HRP) for 1 h at 37 1C. Immunoreactive bands were
visualized by staining the membrane with Super Signal West Pico
(Thermo, USA).
2.8. Reactive oxygen species assay
ROS was detected by the ﬂuorimetric probe dichloro-dihydro-
ﬂuorescein diacetate (DCFH-DA) according to the protocol
provided by the manufacturer. Brieﬂy, Vero cells were
cultured to 80% conﬂuence in 24-well plates with the density
of 5 104 cell/well. The culture media were removed and the
cells were incubated in 500 μL serum-free DMEM containing
DCFH-DA at 10 μmol/L for 1 h. Fluorescence was observed in
microscope.2.9. Proteasome activity
The chymotrypsin-like activity of the 20S proteasome was
determined by using the ﬂuorogenic substrate SLLVY-AMC as
described previously20. Brieﬂy, cell lysates were prepared as
described above without treatment of protease inhibitor. Fresh
cytoplasmic proteins were extracted from Vero cells and the
concentrations of the proteins were determined. 10 μL of cyto-
plasmic protein was incubated with 75 μmol/L ﬂuorogenic sub-
strate SLLVY-AMC in ﬁnal volume of 100 μL assay buffer
(20 mmol/L Tris–HCl, pH 8.0, 1 mmol/L ATP and 2 mmol/L
MgCl2) for 1 h at 30 1C in a 96-well microplate. The ﬂuorescence
product AMC was determined by a microplate reader at an
emission wavelength of 465 nm. The relative activity of the
proteasome was normalized to the concentration of the cytoplasmic
protein.2.10. Statistical analysis
The results of experiments are shown as average with standard
deviation. Paired t-tests were performed. P values less than 0.05
were considered signiﬁcant differences and are indicated by
asterisks in the ﬁgures.3. Results
3.1. Curcumin inhibits EV71 replication
Previous studies have shown that curcumin has antiviral activities
against human immunodeﬁciency virus (HIV), herpes simplex
virus, HCV and CVB319,20,24,25. In this study, we evaluated the
effect of curcumin on the replication of EV71 in vitro. Vero cells
were infected with EV71 at MOI¼10 and cultured for 8 h in the
medium containing 40 μmol/L curcumin which was added at 1 h
after post-infection (p.i.). We observed that EV71 infection
induced a typical cytopathic effect of rounded cell shape and
condensed nuclei. However, EV71-infected cells treated with
curcumin had no signiﬁcant morphological alterations compared
with the uninfected cells (Fig. 1A). Quantitative real-time PCR and
Western blot analyses showed that curcumin signiﬁcantly
decreased the production of EV71 RNA and almost completely
Figure 1 Curcumin inhibits EV71 replication. (A) Cells were infected with EV71 and cultured in the medium containing 40 μmol/L curcumin for 7 h,
after which were stained with Hoechst33342 to view the nuclei. (B) Cells were treated as described in (A). EV71 RNA level was determined by RT-qPCR
and normalized to the RNA level of GAPDH. **Po0.01 compared with uninfected cells. (C) Cells were treated as described in (A) and virus titer was
determined by TCID50. **Po0.01 compared with EV71-infected cells without curcumin treatment. (D) EV71-infected cells were treated with curcumin at
various concentrations. Proteins were extracted and western blot analysis was performed with anti-VP1 antibody. (E) Cells were infected with EV71 for 8 h
and curcumin was added to the culture medium at various time points after p.i. Cells were stained with Hoechst33342 to view the nuclei. (F) Cells were
infected with EV71 for 8 h and curcumin was added to the culture medium at various time points after p.i. Proteins were extracted and VP1 was analyzed by
western blotting. Error bars show standard deviations. n¼4. Results are representative of three independent infection experiments.
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yield declined about 106-fold in curcumin-treated cells compared
with that in untreated cells (Fig. 1C).To determine the stage of viral replication that was affected by
curcumin, cells were infected with EV71 (MOI¼10) and cultured
in the medium containing curcumin. We found that CPE was
Figure 2 The antiviral effect of curcumin does not depend on its antioxidant activity. (A) Cells were pretreated with curcumin or NAC for 2 h,
and then were infected with EV71 and cultured in the media with no curcumin or NAC supplement for 8 h. Cells were stained with DCFH-DA to
view the production of ROS. Cell nuclei were stained with Hoechst33342. (B) Cells were pretreated with curcumin or NAC at various
concentrations for 2 h and then infected with EV71 for 8 h in the media with no curcumin or NAC supplement. VP1 was analyzed by western
blotting. Results are representative of three independent infection experiments.
Ying Qin et al.288suppressed when curcumin was added to the medium shortly after
viral infection (at 1 h after p.i.) (Fig. 1E). Correspondingly, the
expression of VP1 was also signiﬁcantly inhibited when cells were
treated with curcumin at 1 h after p.i.. These data indicate that
curcumin could effectively inhibit EV71 replication when it was
applied at the early stage of EV71 replication.3.2. The anti-EV71 effect of curcumin does not depend
on its antioxidant activity
Accumulating evidence suggests that oxidative stress affects the
interaction between viruses and cells by providing a favorite
cellular environment for the replication of viral pathogens26,27.
Since curcumin is a natural phenolic compound with impressive
antioxidant property27–30, we investigated whether the antioxidant
property of curcumin is involved in its antiviral activity. Cells
were pretreated with curcumin for 2 h and then infected with EV71
(MOI¼10) for 8 h in the media with no curcumin supplement.
The production of ROS was measured by staining the cells with
DCFH-DA. As shown in Fig. 2, EV71 infection induced a
signiﬁcant increase in the production of ROS, while ROS
production was blocked by the pretreatment of curcumin
(Fig. 2A). Pretreatment with curcumin or the potent antioxidant
NAC did not block CPE in EV71-infected cells (Fig. 2A). Western
blot analysis showed that pretreatment with either curcumin or
NAC did not inhibit the synthesis of VP1 (Fig. 2B). These data
show that curcumin pretreatment did not protect the cells against
EV71 infection, even thought the production of ROS was
inhibited. Thus, the antioxidant property of curcumin did notendow the anti-EV71 capability to the cells. These results indicate
that the antiviral effect of curcumin does not depend on its
antioxidant property.3.3. The antiviral effect of curcumin is not related
with the activation of ERK
It has been reported that MAPK-ERK signaling pathway is
required for the replication of EV71. EV71 replication was
signiﬁcantly decreased when mitogen activated protein kinase
(MAPK) pathway was inhibited by siRNA or speciﬁc inhibitory
drug31–33. In addition, previous studies suggested that curcumin
could also affect MAPK pathway34–36. To investigate whether the
antiviral mechanism of curcumin is related with its inﬂuence on
ERK, we analyzed the alteration of ERK1/2 in EV71-infected cells
treated with curcumin. Cells were infected with EV71 and
curcumin at various concentrations was added to the media at
1 h after p.i. As shown in Fig. 3, curcumin treatment alone
signiﬁcantly increased ERK1/2 phosphorylation, while EV71
infection further elevated the levels of the phosphorylated
ERK1/2. In the meantime, VP1 expression was signiﬁcantly
decreased by the treatment of curcumin at 20 and 40 μmol/L.
These results show that both curcumin treatment and EV71
infection promotes the activation of ERK1/2. These data also
indicate that the anti-EV71 activity of curcumin overcomes the
effect of ERK activation, which might be beneﬁcial to the
replication of EV71. In other words, ERK activation was not
involved in the antiviral mechanism of curcumin.
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during EV71 infection
Studies in the recent years have demonstrated that UPS can also be
re-directed to favor viral replication37–41. In addition, curcumin has
been reported to inhibit the production of Japanese encephalitis
virus and dengue virus by dysregulating UPS42,43. To study
whether UPS is involved in the antiviral effect of curcumin, cells
were infected with EV71 for 8 h and 40 μmol/L curcumin was
added to the culture medium at 1 h after p.i. The activity of
proteasomes was determined at 5 h of p.i. The levels of p53 and
p21 were also determined since both proteins are degraded through
UPS. As shown in Fig. 4, VP1 expression was signiﬁcantly
inhibited by the treatment of curcumin or MG132 (Fig. 4A). Since
MG132 directly suppresses the activity of proteasomes, these data
indicate that functional proteasome is required for EV71 replication,Figure 3 The antiviral effect of curcumin was not related with the
activated ERK. Cells were infected with EV71 for 8 h and curcumin
was added to the culture medium at 1 h after p.i. Cell lysates were
probed by the antibodies against VP1, ERK1/2 and phosphorylated
ERK1/2 (p-ERK1/2) in western blot analysis. Results are representa-
tive of three independent infection experiments.
Figure 4 Curcumin suppresses the activity of ubiquitin-proteasome during
or MG132 was added to the culture medium at 1 h after p.i. VP1 was analy
5 h after p.i., the activity of the proteasomes was determined. *Po0.05 com
treatment; **Po0.01 compared with the cells infected with viruses withou
was added to the culture medium at 1 h after p.i. The levels of p53, p21
standard deviations. Results are representative of three independent infectiand inhibiting the activity of proteasomes is sufﬁcient to block viral
replication. We further measured the in vitro activity of proteasomes
in virus-infected cells. We observed that the activity of proteasomes
was increased by EV71 infection, while it was reduced by the
treatment of curcumin in virus-infected cells (Fig. 4B). Correspond-
ingly, viral infection promoted the degradation of p53 and p21,
while the levels of both proteins were increased by the treatment of
curcumin in virus-infected cells (Fig. 4C). However, curcumin
per se did not alter the level of p53 and p21 (Fig. 4C) in sham-
infected cells, indicating that curcumin has no impact on UPS in
normal cells. These data imply that the inhibitory effect of curcumin
on UPS during EV71 infection might be the result of the suppressed
viral replication.3.5. Curcumin down-regulates GBF1 and PI4KB
during EV71 infection
Studies have demonstrated that CVB3 uses its non-structural
protein 3A to form replication complex. The assembly of the viral
replication complex is facilitated by a guanine nucleotide
exchange factor, GBF144–46. Moreover, to form the replication
complex, cytoplasmic membrane containing speciﬁc phospholipid,
phosphatidylinositol 4-phosphate (PI4P), is also indispensible for
the recruitment of viral RNA-dependent RNA polymerase47–49.
Since PI4KB is the enzyme that catalyzes the formation of PI4P, it
is also required for the replication of EV7148,50. In this study, we
studied whether curcumin achieves its anti-EV71 effect by
inﬂuencing GBF1 or PI4KB. RD cells were infected with EV71
and cultured in the medium containing 40 μmol/L curcumin for
8 h. Western blot analysis showed that curcumin treatment
signiﬁcantly decreased the expression of both GBF1 and PI4KB
in the cells infected with EV71 as well as in control cells (Fig. 5A–D).
The reduced level of both GBF1 and PI4KB might be the results ofEV71 infection. (A) Cells were infected with EV71 for 8 h. Curcumin
zed by western blotting. (B) Cells were treated as described in (A). At
pared with sham-infected cells or the cells infected with EV71 without
t treatment. (C) Cells were infected with EV71 for 8 h and curcumin
and VP1 were determined by western blotting. Error bars represent
on experiments.
Ying Qin et al.290decreased synthesis or increased degradation of these proteins. Our
results also show that EV71 infection signiﬁcantly increased the level
of PI4KB, while the level of GBF1 was not altered (Fig. 5C and D).
Since EV71 promotes the activity of proteasomes (Fig. 4), the
increased PI4KB level was likely due to promoted protein synthesis
rather than its inhibited degradation. The treatment of curcumin
signiﬁcantly decreased the levels of GBF1 and PI4KB in EV71-
infected cells (Fig. 5A–D). These data indicate that GBF1 and PI4KB
are among the target proteins that are inﬂuenced by curcumin,
indicating its down-regulatory effect on GBF1 and PI4KB.
To further study the involvement of GBF1 and PI4KB in the
replication of EV71, RD cells were treated with the siRNA of
either GBF1 or PI4KB for 48 h and then infected with EV71 for
8 h. Western blot analysis showed that the synthesis of VP1 was
signiﬁcantly declined when the expression of GBF1 or PI4KB was
inhibited (Fig. 5E). Taken together, these results indicate that both
GBF1 and PI4KB are required for EV71 replication, and theFigure 5 Curcumin down-regulates GBF1 and PI4KB during EV71 inf
added to the culture medium at 1 h after p.i. Cell lysates were probed with
(A). Cell lysates were probed by antibodies against PI4KB and VP1. (C) an
bands in A and B. ** Po0.01 compared with normal cell control (NC). (E
then infected with EV71 for 8 h. The levels of PI4KB, GBF1 and VP1 wer
n¼4. Results are representative of three independent experiments.inhibition of either of them would signiﬁcantly impact viral
replication. These data also suggest that GBF1 and PI4KB might
be involved in the anti-EV71 mechanism of curcumin.3.6. Cucumin suppresses apoptosis induced by EV71 infection
Apoptosis is often targeted by viruses to beneﬁt their replication51–54.
To investigate how curcumin inﬂuences virus-induced apoptosis, Vero
cells were infected with EV71 and grown in the medium containing
curcumin for 8 h. The nuclear morphological alteration was observed
by staining cells with Hoechst33342. The activated caspase 3 and
PARP-1 were analyzed by western blotting. As shown in Fig. 6, cells
infected with EV71 predominantly contained condensed nuclei, while
the virus-infected cells treated with 40 μmol/L curcumin showed no
signiﬁcant abnormality in morphology. Western blot analysis showed
that the levels of cleaved caspase-3 and PARP-1 were increased byection. (A) Cells were infected with EV71 for 8 h and curcumin was
antibody against GBF1 and VP1. (B) Cells were treated as described in
d (D) The relative quantity of GBF1 and PI4KB in the electrophoresis
) Cells were transfected with siRNA of PI4KB or GBF1 for 48 h and
e determined by western blotting. Error bars show standard deviations.
Figure 6 Curcumin suppresses apoptosis induced by EV71 infection. (A) Vero cells were infected with EV71 and grown in the medium
containing curcumin for 8 h. Cells were stained with Hoechst33342 to view the nuclei. (B) Cells were infected with EV71 for 8 h and curcumin
was added to the culture medium at 1 h after p.i. PARP-1, cleaved caspase 3 and VP1 were determined by western blotting. Cells treated with
DMSO were used as controls. (C) Cells were infected with EV71 for 8 h. Curcumin was added to the culture medium at various time points after p.
i. PARP-1, cleaved caspase 3 and VP1 were determined by western blotting. Results are representative of three independent infection experiments.
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(Fig. 6B). The levels of both PARP-1 and cleaved caspase-3 were
declined by the treatment of 40 μmol/L curcumin (Fig. 6B), indicating
that curcumin suppressed the apoptosis induced by viral infection.
However, curcumin treatment did not alter the levels of both proteins in
sham-infected cells (Fig. 6B), indicating that curcumin has no impact
on apoptosis when it is applied to normal cells. We also demonstrated
that decreased PARP-1 and cleaved caspase-3 occurred only when
curcumin was added to the medium shortly after EV71 infection (at 1 h
after p.i.), corresponding to the inhibited expression of VP1 (Fig. 6C).
These data collectively indicate that curcumin could suppress the
apoptosis induced by EV71 when it is applied at the early stage of viral
infection.4. Discussion
EV71 is one of the major causative pathogens of hand, foot and
mouth disease (HFMD) which may lead to severe and fatal
damage of central nervous system, heart failure and pulmonary
edema55,56. Twenty-one fatal cases were reported during the
outbreak of HFMD in Guangdong Province of China in 200857.
During the outbreaks of HFMD in China, herbal extracts of
traditional Chinese medicine have been used as adjuvant treatment
and encouraging therapeutic effect against viral infection has been
obtained58–60. The therapeutic antiviral effect of medicinal herbs
inspired us to study the anti-EV71 efﬁcacy of curcumin, which has
been widely used as an ingredient of traditional medicine around
the world. To our knowledge, this is the ﬁrst study to show that
curcumin suppressed EV71 replication in vitro.
As a natural compound, curcumin has been reported to have
antiviral activity against inﬂuenza virus, Rift Valley Fever virus,
CVB and HCV14,20,25,61. In this study, we demonstrated that the
application of curcumin at the early stage of EV71 replication
signiﬁcantly suppressed viral RNA synthesis, viral protein expres-
sion and the overall viral progeny production. Our data indicate
that curcumin has potent anti-EV71 effect in vitro.
Previous evidence suggests that oxidative stress is involved in
the pathogenesis of viral infections. Studies showed that increased
oxidative stress induced by selenium-deﬁcient diet exacerbated themyocarditis of mice after CVB3 infection62,63, and disrupting
cellular redox balance effectively promoted EV71 replication and
cell death64,65. In addition, attenuated production of ROS reduced
the EV71 replication66. In consistent with the reported studies, we
found that EV71 infection did induce a signiﬁcant increase of
ROS. However, the inhibited production of ROS in cells treated
with curcumin or the ROS scavenger NAC prior to viral infection
did not show suppressive effect on both viral replication and cell
death. This study indicates that the anitioxidant activity of
curcumin is not involved in its antiviral effect. Our study also
indicates that targeting ROS alone is not sufﬁcient to suppress
EV71 replication. However, further studies are needed to elucidate
the role of ROS in EV71 replication.
Previous study showed that the activation of ERK was required
for EV71 replication67. On the other hand, curcumin has been
reported to target ERK signaling in cancer cells68,69. Unlike the
effect of curcumin on cancer cells, in which p-ERK was decreased
by the treatment of curcumin68,70, the present study demonstrated
that ERK was activated by curcumin. Moreover, it seems that
curcumin treatment and EV71 infection had synergetic effect on
ERK activation. However, EV71 replication was still effectively
inhibited by the treatment of curcumin even through ERK was
highly active. If the activated ERK is required for EV71 replica-
tion as it was previously reported31,67, our data indicate that ERK
activation is not sufﬁcient to support viral replication. We can also
infer that ERK pathway is not involved in the anti-EV71
mechanism of curcumin.
Ubiquitin–proteasome system is essential for cells to regulate
short-lived proteins involved in critical cellular processes such as
DNA replication, cell cycle control and immune reactions71,72.
Previous study showed that curcumin induced the degradation of
ErB2 protein by promoting the association of ErB2 with ubiquitin
ligase CHIP73, while Ben et al.74 reported that curcumin promoted
the degradation of the inducible nitric oxide synthase by up-
regulating ubiquitination. The study of Si et al.20 has demonstrated
that curcumin suppresses CVB3 replication through inhibiting the
activity of proteasomes and the cellular deubiquitinating process.
In this study, we found that the addition of proteasome inhibitor
MG132 completely blocked EV71 replication. These results
indicate that UPS is indispensible for the replication of EV71.
Ying Qin et al.292However, unlike the previous studies, we found that curcumin
showed no impact on UPS in sham-infected cells, but curcumin
did suppress the degradation of p53 and p21 in EV71-infected
cells. Since we did not study whether or not curcumin could
directly inﬂuence the activity of proteasomes or the process of
unbiquination, here we could not conclude that the accumulation
of p53 and p21 is resulted from the direct inhibition of curcumin
on UPS. It could also be the consequence of the suppressed viral
replication. Therefore, the precise role of UPS in the anti-EV71
mechanism of curcumin remains to be studied further.
The critical role of cytoplasmic membrane in the replication of
viruses has been recognized during the past few years48,75,76.
Studies have shown that RNA viruses such as CVB3, poliovirus
and Aichi virus, utilize cytoplasmic membrane to form replication
complex48,75,76. To form the replication complex, 3A protein of
CVB3 is required to bind the cytoplasmic membranes enriched in
PI4P, which is converted from phosphatidylinositol by PI4KB. In
addition, the binding of CVB3 3A to organelle membranes requires
GBF1, a guanine nucleotide exchange factor (GEF). Other studies
showed that inhibitor of PI4KB showed signiﬁcant antiviral effect
against poliovirus77, and knockdown of PI4KB could signiﬁcantly
inhibit HCV replication78. Here we found that curcumin showed
antiviral effect at the early stage of EV71 infection when viral RNA
replication is the major event. Therefore, we proposed that curcumin
may suppress EV71 replication by interfering with the formation of
viral replication complex. We demonstrated that the expression of
both GBF1 and PI4KB were signiﬁcantly suppressed by curcumin
in EV71-infected and in sham-infected cells. More importantly, the
decreased expression of GBF1 and PI4KB by siRNAs directly
inhibited the replication of EV71, indicating that EV71 replication
requires both GBF1 and PI4KB. However, we cannot jump to the
conclusion from the present data that the down-regulated GBF1 and
PI4KB contribute to the anti-EV71 mechanism of curcumin. The
precise role of GBF1 and PI4KB in the antiviral effect of curcumin
may be demonstrated by blocking the down-regulatory effect of
curcumin on these two proteins. On the other hand, considering the
fact that GBF1 and PI4KB are important molecules for the
formation of viral replication complex for picornaviruses, it is
possible that these two proteins are involved in the anti-EV71
mechanism of curcumin.
Apoptosis is the common target of many types of viruses to
promote their replication or viral release. In addition, curcumin has
been reported to induce apoptosis in a variety of cancer cell
lines48,50,69,79. To evaluate the role of apoptosis in the antiviral
mechanism of curcumin, we examined the cellular morphological
changes and the activation of enzymes required for apoptosis. We
found that apoptosis was induced by EV71 infection. However,
unlike the reported promoting effect of curcumin on apoptosis in
cancer cells, we found that curcumin had no impact on apoptosis
in sham-infected cells, while it signiﬁcantly suppressed apoptosis
in EV71-infected cells. However, whether the inhibited apoptosis
is the direct function of curcumin or the consequence of the
suppressed viral replication remains unclear. In spite of this, our
data still demonstrated that curcumin has antiviral and cellular
protective activity in EV71-infected cells.5. Conclusions
In summary, this study demonstrated that curcumin showed potent
antiviral effect against EV71 infection. The antiviral mechanism of
curcumin was related with neither its antioxidant activity nor itsimpact on ERK pathway. The present study also showed that
EV71 replication requires GBF1 and PI4KB, and both proteins
were down-regulated by the treatment of curcumin in EV71-
infected cells. However, the role of GBF1 and PI4KB in the anti-
EV71 mechanism of curcumin needs further studies. Furthermore,
this study showed that curcumin suppressed UPS and apoptosis in
EV71-infected cells. Therefore, curcumin could be a potential anti-
EV71 natural compound with both antiviral and cellular protective
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